Notes: TW = Therapeutic Wand, BPS = Bladder Pain Syndrome, PFM MFR = Pelvic Floor Muscle Myofascial Release
Jilly Bond MSc MCSP MPOGP MAACP
Jilly Bond, a renowned physical therapist that specializes in pelvic health, recently published a clinical paper titled, “Efficacy of a therapeutic wand in addition to physiotherapy for treating bladder pain syndrome in women.” This study conducted randomized controlled trials in order to test the efficacy of the TheraWand at relieving symptoms experienced by women suffering from pelvic disorders, specifically Bladder Pain Syndrome (Interstitial Cystitis).
The trial consisted of two different groups. Although each group attended pelvic therapy sessions for six weeks, only one group continued to treat their disorders at home after the sessions using a therapeutic wand (TW).
Although the paper suggests further studies can be done, “A significant reduction was observed in the pelvic pain of 94% of patients using the TW three to four times a week for 4-6 months (Bond et al, 2017).” The study does inquire what percentage of reduction in pelvic pain is from physically addressing the pelvic floor compared to the psychological reduction in pain because a “Patients’ self-efficacy can be improved by providing them with self-management tools (Dufour et al. 2015), ...known to improve their perception of pain and disability (Denison et al. 2004).”
The paper’s findings seem to point to the fact that use of the wand does improve the well-being of the user. Jilly Bond wrote that “After 6 weeks of physiotherapy treatment, the TW group demonstrated a greater reduction in all symptoms and bother scores than the control group… [and that] the TW represents a potential BPS self-management strategy, giving sufferers the opportunity for timely treatment of their symptom flare-ups instead of waiting for a physiotherapy appointment (Bond et al, 2017).”
Being able to treat your symptoms in the comfort of your own home is a fundamental principle for our TheraWands ; although we do strongly recommend consulting with a physical therapist that specializes in pelvic health prior to using our Wands as they can provide individualized instruction.
In Jilly Bond’s concluding statement she stated, “The findings of the present study suggest that the TW may provide for a suitable and safe self-management tool for patients suffering from BPS. This would potentially give sufferers the opportunity for timely treatment of symptom flare-ups instead of having to wait for a physiotherapy appointment. Patients who are averse to hospital-based intravaginal treatment or unable to attend it would have the option of accessing the known benefits of PFM MFR (Pelvic Floor Muscle Myofascial Release) independently in their own home, and the pressure on stretched physiotherapy departments to provide labor-intensive treatment might be reduced (Bond et al, 2017).”
While the studies conducted during this paper may have reported positive results related to the use of a therapeutic wand for self-treatment, no clear conclusion can be reached without further testing. The small sample size as well the theory that any improvement in health could have been related to the idea that self-efficacy can create a sort of “placebo effect” on patients must be considered when discussing the results of this clinical paper.